Today, the production of induced pluripotent stem cells (iPS) is an excellent method for creating human model systems for studying rare genetic diseases, about which little is yet known. The subsequent differentiation into any kind of cell, and in particular, into cells from the nervous system, means that this model can be extended to include neurodegenerative and neurodevelopmental diseases in general, both hereditary and non-hereditary.
5 aprile
The seminar will be held by Dott.ssa Jessica Rosati of the Fondazione IRCCS Casa Sollievo della Sofferenza
Istituto Mendel, Roma, in room C (building CU010) at 12:00.